mAbs | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,493 results for “mAbs”

Trials

View all 1648 →

Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments

100 participants · First posted Aug 20, 2024

Biochemical Profiling of Migraine Patients

100 participants · First posted Aug 12, 2024

MABs Therapy m.3243A>G Mutation Carriers

6 participants · First posted Oct 1, 2021

Drugs

View all 442 →

MABS-139

MABS-02

MABS-140

Organizations

View all 98 →

Y-mAbs Therapeutics

United States

Y-Mabs Therapeutics Inc.

Denmark

BioAtla

United States

News

View all 305 →

Y-mAbs Announces Strategic Realignment and Positive Preliminary Data for SADA PRIT Platform

Oppenheimer Predicts Significant Growth for Sagimet and Y-mAbs Therapeutics

Y-mAbs Therapeutics Restructures Pipeline Following FDA Rejection of Neuroblastoma Drug Omburtamab

Page 1 of 250